Effectiveness and Suitability of the Online Mobile Application for the Mental and Physical Health of Cancer Patients
Launched by MASARYK UNIVERSITY · Jan 27, 2022
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well an online mobile application called MOÚ MindCare can help improve the mental and physical health of cancer patients. The researchers want to see if using this app can reduce feelings of stress, anxiety, and depression, as well as help with sleep problems, fatigue, and other health issues. The goal is to find out if this app can provide valuable support to people who are dealing with cancer.
To participate in this study, you need to be at least 18 years old and have a diagnosis of cancer. You should be currently receiving treatment for cancer or have completed treatment. However, if you do not have a smartphone or internet access, or if you have certain psychiatric conditions that affect your daily life, you may not be eligible to join. If you decide to take part, you can expect to use the app as part of the study and report on how it affects your overall well-being. This could be a great opportunity to enhance your support during your cancer journey.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Men and women over the age of 18
- • Diagnosis of some kind of cancer
- • Receiving some form of cancer treatment or finished cancer treatment
- Exclusion Criteria:
- • Patients without a mobil device ("smart" mobile phone)
- • Patients without internet access
- • Patients suffering from some psychiatric disorder (Schizophrenia, Bipolar Affective Disorder, personality disorder associated with mood changes, Posttraumatic Stress Disorder, suicide attempt, suicide thoughts, Somatoform Disorder or other medically unexplained symptoms which, due to their severity, prevent the person concerned from daily life
- • Patients suffering during the last year from: depression with psychotic symptoms, panic anxiety, repeated hospitalization in psychiatry
About Masaryk University
Masaryk University, located in Brno, Czech Republic, is a leading academic institution renowned for its commitment to advancing research and education in the life sciences and clinical fields. As a sponsor of clinical trials, the university leverages its extensive resources, including state-of-the-art laboratories and a multidisciplinary team of experts, to conduct innovative research that addresses critical health challenges. With a focus on ethical standards and regulatory compliance, Masaryk University aims to contribute to the development of new therapeutic approaches and improve patient outcomes through rigorous scientific inquiry and collaboration with healthcare partners.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brno, Bohunice, Czechia
Patients applied
Trial Officials
Miroslav Světlák, PhD
Study Chair
Masaryk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials